# Spyre Therapeutics, Inc.: Form 8-K, filed Apr 13, 2026

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: 8-K
- Filed: 2026-04-13
- Accepted by EDGAR: Apr 13, 2026, 20:29 ET
- Period: 2026-04-13
- Accession: 0001628280-26-024906
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000162828026024906/syre-20260413.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000162828026024906/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000162828026024906/syre-20260413.htm

Filed Apr 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-024906. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.